EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

COVID-19 and Neonatal Guillain-Barré Syndrome: Exploring a Possible Causal Link With Review of Literature

Choudri Muzafar Paswal iD, Neeraj Gupta iD, Swasthi Kabi Satpathy iD, Hemant Kumar, Sushil Kumar Choudhary iD, Lokesh Saini iD, Arun Kumarendu Singh, Sarbesh Tiwari iD

Journal of Child Neurology · 2026

DOI: 10.1177/08830738251413670 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Child Neurology, 2026. Verfasst von Choudri Muzafar Paswal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Hauptthemen laut MEDLINE: COVID-19, Guillain-Barre Syndrome. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Guillain-Barré Syndrome (GBS) is an immune-mediated polyneuropathy that is rare in neonates. It may be acquired congenitally via maternal antibody transfer or postnatally after infection. We report a case of postnatally acquired neonatal GBS potentially triggered by SARS-CoV-2 with a review of the literature. Patient A 24-day-old term male presented with progressive hypotonia, a weak cry, and respiratory distress. He had a preceding febrile illness with gastrointestinal symptoms. Examination revealed areflexia, cranial nerve involvement, and generalised weakness.

Results

Investigations showed albuminocytologic dissociation in cerebrospinal fluid, cauda equina enhancement on magnetic resonance imaging, and motor-sensory polyneuropathy on nerve conduction studies. The infant had high anti-SARS-CoV-2 IgG (>4000 IU/mL) with negative maternal titres. After 2 courses of intravenous immunoglobulin (IVIg), he recovered fully and remained developmentally normal at 2-year follow-up.

Conclusion

GBS should be considered in floppy neonates with a postinfectious presentation. This case highlights the possibility of SARS-CoV-2 as a postnatal trigger and the importance of early recognition and treatment with IVIg.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Guillain-Barre SyndromeHumansInfant, NewbornMaleImmunoglobulins, IntravenousPandemicsSARS-CoV-2

Stichwörter der Autor:innen

Guillain-Barré Syndrome (GBS)SARS-CoV-2cauda equina enhancementfloppy infantneonatal hypotonia

Substanzen

Immunoglobulins, Intravenous

Autor:innen und Institutionen

  • Department of Neonatology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
  • Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
  • Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.

ORCID-Profile: Choudri Muzafar Paswal, Neeraj Gupta, Swasthi Kabi Satpathy, Sushil Kumar Choudhary, Lokesh Saini, Sarbesh Tiwari

Zitieren

APA

Paswal, C. M., Gupta, N., Satpathy, S. K., Kumar, H., Choudhary, S. K., Saini, L., Singh, A. K., & Tiwari, S. (2026). COVID-19 and Neonatal Guillain-Barré Syndrome: Exploring a Possible Causal Link With Review of Literature. Journal of Child Neurology. https://doi.org/10.1177/08830738251413670

Vancouver

Paswal CM, Gupta N, Satpathy SK, Kumar H, Choudhary SK, Saini L, et al. COVID-19 and Neonatal Guillain-Barré Syndrome: Exploring a Possible Causal Link With Review of Literature. Journal of Child Neurology. 2026. doi:10.1177/08830738251413670

BibTeX
@article{Paswal2026,
  author = {Paswal, Choudri Muzafar and Gupta, Neeraj and Satpathy, Swasthi Kabi and Kumar, Hemant and Choudhary, Sushil Kumar and Saini, Lokesh and Singh, Arun Kumarendu and Tiwari, Sarbesh},
  title = {COVID-19 and Neonatal Guillain-Barré Syndrome: Exploring a Possible Causal Link With Review of Literature},
  journal = {Journal of Child Neurology},
  year = {2026},
  doi = {10.1177/08830738251413670}
}
Kostenlos starten →